Aberrant methylations in cancer cells: where do they come from?
about
MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancerRole of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric CarcinogenesisPerspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsAnalysis of tissue-specific differentially methylated regions (TDMs) in humansSusceptibility to human cancer: From the perspective of a pathologist.Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1.Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence.DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cellsMethylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia.Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats.The application of methylation specific electrophoresis (MSE) to DNA methylation analysis of the 5' CpG island of mucin in cancer cells.Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction.Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.Histone methylation and acetylation indicates epigenetic change in the aged cochlea of mice.Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide.CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell linesEpigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation.Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins.Cellular and molecular basis for endometriosis-associated infertility.Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive ImpairmentThe prima donna of epigenetics: the regulation of gene expression by DNA methylation.Applying whole-genome studies of epigenetic regulation to study human disease.Immunoepigenetics: the unseen side of cancer immunoediting.Framework analysis for the carcinogenic mode of action of nitrobenzene.Programming the genome in embryonic and somatic stem cells.Quantitative analysis of human tissue-specific differences in methylation.Second-hand smoke and human lung cancerDNA methylation: a marker for carcinogen exposure and cancer riskSenescence induction; a possible cancer therapy.High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome.Cancer epigenomics: implications of DNA methylation in personalized cancer therapy.The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islandsAge-related epigenetic drift in the pathogenesis of MDS and AML.Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.Role of DNA methylation in the development of diffuse-type gastric cancer.DNA methylation and nonsmall cell lung cancer.Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation.DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis.
P2860
Q26751780-D8655E99-8089-4C5E-BBA6-90BF756F07C5Q26765643-E2EA09B9-8D98-49C0-B112-C94EABCAA7E9Q27012898-F6DA329A-C316-44AE-A9FB-08D57E78D964Q28762983-230D9C65-B73F-4FFA-A7A3-F40800424D66Q30250217-9A5346B4-6ADF-4FFB-A3B2-63147C29F69DQ30425294-20458017-BF98-48C2-940F-0A5E4FC3131AQ33286093-37B39801-CF1D-4462-8047-0FCEE2728E3AQ33621598-6ADF6C06-3265-4806-AAEF-0478A68083DAQ33775531-0B082B0E-E28E-48BE-8A7C-BD148DC95D17Q33855895-E77535D8-AB0C-4000-9273-A9A69A806C50Q33974223-D5A338F3-4C5E-41C3-AFBB-3B94200A6769Q34157531-6425C504-B03F-4CB9-99A7-4D167F2BDEB0Q34193813-6A5ABFB0-2AD3-4543-9047-16D1EB9E7DE1Q34277489-C244A78E-348A-4C09-932F-EE88971E33A0Q34451733-C98B211A-A481-47B1-ACEA-E553ED73489FQ34488011-3A2414F7-879A-4959-8613-4135D8773AE1Q34599904-23002B54-059C-4A79-B0C8-749ADAFF5333Q35001966-F48BDFCA-ADAC-4B07-BD0B-0BC1A231DF0EQ35109954-17E1F2D5-A890-453A-95C0-DD9FFDE512CEQ35607381-935BEB2B-282E-4DD6-B568-EA5A267641C1Q36195426-0A88104F-9E5B-4BB8-BA9C-D7D931628F23Q36228525-E4741071-39A1-408F-8B7C-C1D452CD0719Q36261732-368BB9C2-2315-4C0D-ACF6-80C5AC25AB06Q36485572-B546C4BE-CAF5-49EC-824A-E4DCCB8FEB21Q36666346-BD575450-9449-4913-B1ED-AAB0ACD5AEDCQ36844974-7956CBBD-8BCC-4717-B44F-F94C5EAAF15FQ36924370-145DDA63-8C4C-4CA0-B553-59D5C396DB7BQ37034721-32AB00E2-8311-44ED-9081-C57D0858F62AQ37206472-7648250E-FD46-463C-8A46-F36AF12B711AQ37232224-8C6A4C2D-7BA5-42E4-A16C-E9659DB083B9Q37365452-450A2EFF-CCFF-4DFC-B43F-EBE8D606ED6BQ37375205-D876BFF0-7726-41B9-AF8E-D6AE855DEC56Q37399404-2E47AA11-9DDC-44CD-8E2A-DABC48AB7518Q37417300-9BCA1752-0155-48B3-A115-524532B2F9D0Q37683456-598080D6-ACA5-4F1F-8070-39F5B551A9D1Q37726126-FA744F7B-B196-47C8-90F9-961F8C5965F0Q37832910-4EE432BC-37D1-4412-83C5-DEE8D3E07B2CQ37940375-BFDC813E-39BF-4A12-98C6-87A196F1FC99Q38018996-F604998E-A76A-433F-AC81-D721723181FEQ38995210-09A64AE2-33E7-4BF7-974A-B31F4673F915
P2860
Aberrant methylations in cancer cells: where do they come from?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Aberrant methylations in cancer cells: where do they come from?
@ast
Aberrant methylations in cancer cells: where do they come from?
@en
type
label
Aberrant methylations in cancer cells: where do they come from?
@ast
Aberrant methylations in cancer cells: where do they come from?
@en
prefLabel
Aberrant methylations in cancer cells: where do they come from?
@ast
Aberrant methylations in cancer cells: where do they come from?
@en
P2860
P1433
P1476
Aberrant methylations in cancer cells: where do they come from?
@en
P2093
Eriko Okochi-Takada
Toshikazu Ushijima
P2860
P304
P356
10.1111/J.1349-7006.2005.00035.X
P577
2005-04-01T00:00:00Z